Achieving Optimal Outcomes in Patients with Narcolepsy: Aligning Treatment Goals with Patients is organized by CME Outfitters, LLC.
Premiere Date: 13-06-2022
Credit Expiration Date: 13-06-2023
Narcolepsy is a devastating, neurological condition characterized by excessive daytime sleepiness (EDS), the most common presenting symptom, as well as cataplexy, hypnagogic hallucinations, and sleep paralysis. Though recent practice guidelines have been released, these guidelines do not include recent U.S. Food and Drug Administration (FDA) approvals with strategies to lower sodium, which may be an ideal treatment option in patients with cardiovascular (CV) comorbidities or risk factors. As patients with narcolepsy often experience residual EDS despite traditional treatment, it is imperative that health care professionals (HCPs) possess the knowledge to identify EDS and skills to integrate effective novel therapies to achieve sustained benefits to optimize patient outcomes.
Join Drs. Bogan, Thorpy, and Weaver for an OnDemand symposium as they discuss evidence-based strategies to reduce EDS and cataplexy, among other symptoms, and restore quality of life and functioning in patients with narcolepsy.
At the end of this CME/CE activity, participants should be able to:
• Explain the patient's journey with narcolepsy, including the extensive impact of work, psychosocial, and daily functioning to overall health.
• Analyze the practice implications using evidence-based screening tools and diagnostic criteria to accelerate the early, accurate diagnosis of narcolepsy.
• Integrate strategies to mitigate CV risk associated with narcolepsy in treatment decision-making.
• Implement evidence-based strategies for the initiation and/or switching of therapies to improve and sustain patient QoL and psychosocial and work functioning.